Back to User profile » Dr Toru Kurata
Paper published by Dr Toru Kurata:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M, Miyashita T, Tajima H, Ninomiya I, Ohta T
Cancer Management and Research 2018, 10:2729-2742
Published Date: 15 August 2018